TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
SER

Serina Therapeutics Inc

Healthcare · Biotechnology

2.10$ -2.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow SER
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – –
– -19.3% -21.6% +77.8% +32.0% -97.3% +83.6% +46.9% +115.6% -62.4%
– – – – – – -91.4% +251.6% +10,280.0% +46.2%
– -40.6% -72.8% -294.3% – – – – -4,193.8% –
– -95.7% +189,200.0% -66.1% -96.9% +442.2% -91.1% +5,105.5% -95.6% +168.2%
– – +26,440.0% -127.2% -94.5% – +19.1% -151.4% -95.6% +168.2%
– – – – – – – – – +25.0%
– – – – – – – +668.7% -71.4% +70.9%
– +83.0% -54.8% +4.4% -4.9% -81.9% +21.8% +667.3% +31.2% +31.8%
– – -109.4% – – – – +3,160.1% -155.7% –
– – – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?